Chidinma Haffner

Disclosure Medical Writer at Merck

Speaker

Chidinma Haffner, BPharm, PhD, is a Disclosure Medical Writer at Merck & Co., Inc., specializing in clinical trial transparency and disclosure strategy. She earned a master’s degree in Neuropharmacology from the University of Oxford, UK, as a 2017 Commonwealth Scholar and later completed a PhD in Cardiovascular Pharmacology at the University of Missouri, Columbia. With a strong foundation in pharmacy, pharmacology, and scientific research, she is passionate about advancing transparency in clinical research. After transitioning into disclosure medical writing in 2023, she has focused on ensuring that complex scientific and clinical data are accurately translated into clear, compliant disclosures for public registries and databases. She is particularly interested in embedding transparency considerations throughout the clinical trial lifecycle and helping make clinical research information accessible to patients, healthcare professionals, researchers, and the broader scientific community. Outside of work, Chidinma enjoys reading detective mystery novels and can often be found immersed in whodunits by authors such as Agatha Christie and Anthony Horowitz.